1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Diagnosis 1.2.3 Treatment 1.3 Market by Application 1.3.1 Global Human Immunodeficiency Virus (HIV) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Diagnostic Centers 1.3.5 Homecare Settings 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Human Immunodeficiency Virus (HIV) Market Perspective (2016-2027) 2.2 Human Immunodeficiency Virus (HIV) Growth Trends by Regions 2.2.1 Human Immunodeficiency Virus (HIV) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Human Immunodeficiency Virus (HIV) Historic Market Share by Regions (2016-2021) 2.2.3 Human Immunodeficiency Virus (HIV) Forecasted Market Size by Regions (2022-2027) 2.3 Human Immunodeficiency Virus (HIV) Industry Dynamic 2.3.1 Human Immunodeficiency Virus (HIV) Market Trends 2.3.2 Human Immunodeficiency Virus (HIV) Market Drivers 2.3.3 Human Immunodeficiency Virus (HIV) Market Challenges 2.3.4 Human Immunodeficiency Virus (HIV) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue 3.1.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue (2016-2021) 3.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2016-2021) 3.2 Global Human Immunodeficiency Virus (HIV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Revenue 3.4 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio 3.4.1 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Revenue in 2020 3.5 Human Immunodeficiency Virus (HIV) Key Players Head office and Area Served 3.6 Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service 3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Human Immunodeficiency Virus (HIV) Breakdown Data by Type 4.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Type (2016-2021) 4.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2022-2027) 5 Human Immunodeficiency Virus (HIV) Breakdown Data by Application 5.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Application (2016-2021) 5.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Human Immunodeficiency Virus (HIV) Market Size (2016-2027) 6.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type 6.2.1 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) 6.2.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) 6.2.3 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027) 6.3 North America Human Immunodeficiency Virus (HIV) Market Size by Application 6.3.1 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) 6.3.2 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) 6.3.3 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027) 6.4 North America Human Immunodeficiency Virus (HIV) Market Size by Country 6.4.1 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) 6.4.2 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Human Immunodeficiency Virus (HIV) Market Size (2016-2027) 7.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type 7.2.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) 7.2.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) 7.2.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027) 7.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application 7.3.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) 7.3.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) 7.3.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027) 7.4 Europe Human Immunodeficiency Virus (HIV) Market Size by Country 7.4.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) 7.4.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size (2016-2027) 8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type 8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027) 8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application 8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027) 8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region 8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Human Immunodeficiency Virus (HIV) Market Size (2016-2027) 9.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type 9.2.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) 9.2.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) 9.2.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027) 9.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application 9.3.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) 9.3.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) 9.3.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027) 9.4 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country 9.4.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) 9.4.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2016-2027) 10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type 10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027) 10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application 10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027) 10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country 10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Gilead 11.1.1 Gilead Company Details 11.1.2 Gilead Business Overview 11.1.3 Gilead Human Immunodeficiency Virus (HIV) Introduction 11.1.4 Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.1.5 Gilead Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Details 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Introduction 11.2.4 GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.2.5 GlaxoSmithKline Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Introduction 11.3.4 Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.3.5 Johnson & Johnson Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Human Immunodeficiency Virus (HIV) Introduction 11.4.4 Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.4.5 Merck Recent Development 11.5 AbbVie 11.5.1 AbbVie Company Details 11.5.2 AbbVie Business Overview 11.5.3 AbbVie Human Immunodeficiency Virus (HIV) Introduction 11.5.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.5.5 AbbVie Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Bristol-Myers Squibb Business Overview 11.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Introduction 11.6.4 Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.6.5 Bristol-Myers Squibb Recent Development 11.7 Boehringer Ingelheim 11.7.1 Boehringer Ingelheim Company Details 11.7.2 Boehringer Ingelheim Business Overview 11.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Introduction 11.7.4 Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.7.5 Boehringer Ingelheim Recent Development 11.8 Genentech 11.8.1 Genentech Company Details 11.8.2 Genentech Business Overview 11.8.3 Genentech Human Immunodeficiency Virus (HIV) Introduction 11.8.4 Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.8.5 Genentech Recent Development 11.9 Cipla 11.9.1 Cipla Company Details 11.9.2 Cipla Business Overview 11.9.3 Cipla Human Immunodeficiency Virus (HIV) Introduction 11.9.4 Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) 11.9.5 Cipla Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Diagnosis Table 3. Key Players of Treatment Table 4. Global Human Immunodeficiency Virus (HIV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Human Immunodeficiency Virus (HIV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Human Immunodeficiency Virus (HIV) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Human Immunodeficiency Virus (HIV) Market Share by Regions (2016-2021) Table 8. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Human Immunodeficiency Virus (HIV) Market Share by Regions (2022-2027) Table 10. Human Immunodeficiency Virus (HIV) Market Trends Table 11. Human Immunodeficiency Virus (HIV) Market Drivers Table 12. Human Immunodeficiency Virus (HIV) Market Challenges Table 13. Human Immunodeficiency Virus (HIV) Market Restraints Table 14. Global Human Immunodeficiency Virus (HIV) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Human Immunodeficiency Virus (HIV) Market Share by Players (2016-2021) Table 16. Global Top Human Immunodeficiency Virus (HIV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2020) Table 17. Ranking of Global Top Human Immunodeficiency Virus (HIV) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service Table 21. Date of Enter into Human Immunodeficiency Virus (HIV) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2016-2021) Table 25. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Human Immunodeficiency Virus (HIV) Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2016-2021) Table 29. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million) Table 34. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million) Table 61. Gilead Company Details Table 62. Gilead Business Overview Table 63. Gilead Human Immunodeficiency Virus (HIV) Product Table 64. Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 65. Gilead Recent Development Table 66. GlaxoSmithKline Company Details Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Table 69. GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 70. GlaxoSmithKline Recent Development Table 71. Johnson & Johnson Company Details Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Table 74. Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 75. Johnson & Johnson Recent Development Table 76. Merck Company Details Table 77. Merck Business Overview Table 78. Merck Human Immunodeficiency Virus (HIV) Product Table 79. Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 80. Merck Recent Development Table 81. AbbVie Company Details Table 82. AbbVie Business Overview Table 83. AbbVie Human Immunodeficiency Virus (HIV) Product Table 84. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 85. AbbVie Recent Development Table 86. Bristol-Myers Squibb Company Details Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Table 89. Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 90. Bristol-Myers Squibb Recent Development Table 91. Boehringer Ingelheim Company Details Table 92. Boehringer Ingelheim Business Overview Table 93. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Table 94. Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 95. Boehringer Ingelheim Recent Development Table 96. Genentech Company Details Table 97. Genentech Business Overview Table 98. Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 99. Genentech Recent Development Table 100. Cipla Company Details Table 101. Cipla Business Overview Table 102. Cipla Human Immunodeficiency Virus (HIV) Product Table 103. Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million) Table 104. Cipla Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Immunodeficiency Virus (HIV) Market Share by Type: 2020 VS 2027 Figure 2. Diagnosis Features Figure 3. Treatment Features Figure 4. Global Human Immunodeficiency Virus (HIV) Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Ambulatory Surgical Centers Case Studies Figure 7. Diagnostic Centers Case Studies Figure 8. Homecare Settings Case Studies Figure 9. Others Case Studies Figure 10. Human Immunodeficiency Virus (HIV) Report Years Considered Figure 11. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Human Immunodeficiency Virus (HIV) Market Share by Regions: 2020 VS 2027 Figure 14. Global Human Immunodeficiency Virus (HIV) Market Share by Regions (2022-2027) Figure 15. Global Human Immunodeficiency Virus (HIV) Market Share by Players in 2020 Figure 16. Global Top Human Immunodeficiency Virus (HIV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Revenue in 2020 Figure 18. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2016-2021) Figure 19. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2022-2027) Figure 20. North America Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027) Figure 22. North America Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027) Figure 23. North America Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027) Figure 24. United States Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027) Figure 28. Europe Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027) Figure 29. Europe Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027) Figure 30. Germany Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027) Figure 38. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027) Figure 39. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Region (2016-2027) Figure 40. China Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027) Figure 48. Latin America Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027) Figure 49. Latin America Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027) Figure 50. Mexico Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027) Figure 54. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027) Figure 55. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027) Figure 56. Turkey Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Gilead Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 60. GlaxoSmithKline Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 61. Johnson & Johnson Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 63. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 65. Boehringer Ingelheim Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 66. Genentech Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 67. Cipla Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Gilead GlaxoSmithKline Johnson & Johnson Merck AbbVie Bristol-Myers Squibb Boehringer Ingelheim Genentech Cipla